Cetilistat
Sources
registry, as of 2007-04-11Stale
https://clinicaltrials.gov/study/NCT00148382
Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects. Overall status COMPLETED. Phases PHASE1. Lead sponsor Alizyme. Enrollment 80. Conditions Obesity. The purpose of this study is to investigate the amount of metabolites of ATL-962 in the blood and to investigate the effect of ATL-962 on the amount of fat that is excreted in the faeces in subjects who are obese
ClinicalTrials.gov NCT00148382 protocol and results modules